Biopharmaceutics lecture1


Published on

Published in: Health & Medicine, Technology
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Biopharmaceutics lecture1

  1. 1. BIOPHARMACEUTICS Adapted by : S. Campbell-Elliott M. Pharm. Sc. Prepared by : A.S. Adebayo, Ph.D. & M. A Williams. M.S.
  2. 2. General Overview/Definitions <ul><li>Biopharmaceutics - concerned with relationship between the physicochemical properties of a drug in a dosage form and observed therapeutic response after administration. </li></ul><ul><li>Biologic response </li></ul><ul><ul><li>Expressed as alteration of biologic process existing before drug was administered </li></ul></ul><ul><ul><li>Magnitude is related to drug concentration achieved at receptor site. </li></ul></ul><ul><ul><li>The observed effect of drug from a dosage form = inherent pharmacological activity of the drug + its ability to reach the receptor site in appropriate concentration </li></ul></ul><ul><li>Onset, intensity and duration of therapeutic effect drugs depend on biological + dosage form factors </li></ul>
  3. 3. General Overview/Definitions (Cont.) <ul><li>These factors are important for: attaining desired drug conc. in the body + sustaining concentrations for desired length of time + drug removal after desired effect is attained. </li></ul><ul><li>Biopharmaceutics affords a basic understanding of the processes of drug absorption, distribution and elimination + potential effects of dosage form on these processes that can be applied to optimize therapeutic outcome of a patient. </li></ul><ul><li>Dosage form of a drug exerts its major influence on the absorption process </li></ul>
  4. 4. Biopharmaceutics <ul><li>Biopharmaceutics - “ the effects of dosage form and route of administration on the biological effect of a drug” </li></ul><ul><li>-study of factors influencing the presence of drug at the site of absorption and the transfer of the dissolved drug across biomembrane(s) into the systemic circulation. </li></ul><ul><li>Biopharmaceutical methods: application of knowledge of drug release and transport across biomembranes to obtain/predict therapeutic effect from a product on administration to a patient. </li></ul>
  5. 5. Factors Influencing the time course of a drug in plasma <ul><li>The physical/chemical properties of the drug </li></ul><ul><li>Type of dosage form of the drug </li></ul><ul><li>Composition and method of manufacture of the dosage form </li></ul><ul><li>The size of the dose and frequency of administration of the dosage form </li></ul><ul><li>Site of absorption of the administered drug </li></ul><ul><li>Co-administration of other drugs </li></ul><ul><li>Type of food taken by the patient </li></ul><ul><li>The disease state of the patient that may affect drug absorption, distribution and elimination of the drug </li></ul><ul><li>The age of the patient. </li></ul><ul><li>The genetic composition of the patient </li></ul>
  6. 6. Bioavailability: rate & extent <ul><li>Bioavailability - transfer of drug from its site of administration into the body system; manifested by appearance in general circulation. </li></ul><ul><li>Characterized by rate of transfer and the total amount (extent) transferred </li></ul>
  7. 7. Factors Influencing Drug Absorption <ul><li>Can be categorized into 3 factors: </li></ul><ul><ul><li>Physiological factors </li></ul></ul><ul><li>- Nature of the cell membrane </li></ul><ul><ul><li>Semi-permeable: Permits only water, selected small molecules and lipid-soluble molecules. </li></ul></ul><ul><ul><li>Highly charged molecules and large molecules e.g. proteins and protein-bound drug will not cross. </li></ul></ul>
  8. 8. Factors Influencing Drug Absorption <ul><ul><li>Physicochemical factors </li></ul></ul><ul><ul><li>Surface area of the drug </li></ul></ul><ul><ul><li>Crystal or amorphous form </li></ul></ul><ul><ul><li>Salt form </li></ul></ul><ul><ul><li>State of hydration </li></ul></ul><ul><ul><li>Solubility </li></ul></ul>
  9. 9. Factors Influencing Drug Absorption <ul><ul><li>Dosage form factors </li></ul></ul><ul><li>- The route of administration </li></ul><ul><li>- The inert ingredients e.g. diluents, </li></ul><ul><li>binders, disintegrants, suspending </li></ul><ul><li>agents, coating agent, etc. </li></ul><ul><li>-Type of dosage form e.g. tablet, capsule, </li></ul><ul><li>solution,suspension, suppository, etc. </li></ul>
  10. 10. Schematic illustration of the steps involved in the appearance of intact drug in systemic circulation following oral administration of a tablet STOMACH (Gastric content. pH 1-3) SMALL INTESTINE (Intestinal cont. pH 5-7) Tablet Granules Fine particles Dissolution Drug in solution Tablet Granules Fine particles Dissolution Drug in solution Absorption Intact drug Liver Intact Drug in systemic Circulation Pharmacologic effect Intestinal metabolism Metabolites Urine Hepatic Metabolism (1 st Pass Effect) Disintegration Deaggregation
  11. 11. Rate Limiting Steps of Absorption Rate of metabolism of drug during its initial passage through the liver (i.e. First-pass effect). Rate at which drug is metabolized by the enzymes in the intestinal mucosal cells en route into mesenteric blood vessels Rate of gastric emptying into small intestine Other factors Rate of release from the dosage form Dosage Design Rate at which drug crosses membrane of the GIT High aqueous solubility Rate of dissolution in gastrointestinal fluid Poor aqueous solubility Rate Limiting Step Nature of Drug
  12. 12. Physiological Factors Affecting Oral Absorption
  13. 13. Fate of a Drug Product
  14. 14. Simplified Model of Membrane
  15. 15. Davson-Danielli Model
  16. 16. Examples of Biomembranes <ul><li>Blood-brain barrier </li></ul><ul><ul><li>H as effectively no pores to prevent many polar materials (often toxic ) from entering the brain. </li></ul></ul><ul><ul><li>Smaller lipid or lipid soluble materials, such as diethyl ether, halothane (used as general anesthetics) can easily enter the brain. </li></ul></ul><ul><li>Renal tubules </li></ul><ul><ul><li>Relatively non-porous; lipid compounds or non-ionized species (dependent of pH and pKa) are reabsorbed. </li></ul></ul>
  17. 17. Examples of Biomembranes (cont’d) <ul><li>Blood capillaries and renal glomerular membranes </li></ul><ul><ul><li>Quite porous, allowing non-polar and polar molecules (up to a fairly large size, just below that of albumin, (M.Wt. 69,000) to pass through. </li></ul></ul><ul><ul><li>Especially useful in the kidneys as it allows for excretion of polar (drug and waste compounds) substances. </li></ul></ul><ul><ul><li>Placental barrier – Research!!! </li></ul></ul>
  18. 18. Structure of the Gastro-intestinal Tract <ul><li>The GIT consists of 4 anatomical regions : </li></ul><ul><li>Oesophagus </li></ul><ul><li>Stomach </li></ul><ul><li>Small intestine </li></ul><ul><li>Large intestine (colon). </li></ul><ul><li>The luminal surface varies throughout the tract – suited for function </li></ul>
  19. 20. Physiology of the G.I.T. <ul><li>Hollow muscular tube composed of 4 concentric layers of tissues: </li></ul><ul><li>Mucosa (mucous membrane) </li></ul><ul><li>Sub-mucosa </li></ul><ul><li>Muscularis externa </li></ul><ul><li>Serosa (outermost layer ). </li></ul>
  20. 21. Physiology of the GIT : Structure of the wall <ul><li>Serosa – epithelium + connective tissue </li></ul><ul><li>Muscularis externa – moves GI contents </li></ul><ul><li>Submucosa </li></ul><ul><ul><li>Secretory tissue </li></ul></ul><ul><ul><li>Rich supply of blood and lymphatic vessels </li></ul></ul><ul><ul><li>Network of nerve cells </li></ul></ul><ul><li>Mucosa </li></ul>
  21. 22. Physiology of the G.I.T. : The Mucosa <ul><li>Mucosa is most important for drug absorption . </li></ul><ul><ul><li>- It contains the cellular membrane through which a drug must pass in order to reach the blood (or lymph). </li></ul></ul><ul><li>The mucosa is itself made of 3 layers: </li></ul><ul><ul><li>Lining epithelium </li></ul></ul><ul><ul><li>Lamina propria </li></ul></ul><ul><ul><li>Muscularis mucosa </li></ul></ul>
  22. 23. Physiology of the G.I.T.: The Mucous Layer <ul><li>The gastrointestinal epithelium is covered by a layer of mucus. </li></ul><ul><li>Mucuous acts as a protective layer and a mechanical barrier. </li></ul><ul><li>It has a large water component (95%). </li></ul><ul><li>It also contains large glycoproteins (mucin) </li></ul><ul><li>The mucus layer ranges in thickness from 5  m to 500  m along the length of the gastrointestinal tract, with average valves of around 80  m. </li></ul><ul><li>The layer is thought to be continuous in the stomach and duodenum </li></ul>
  23. 24. Physiology of the GIT: The Oesophagus <ul><li>Links the oral cavity with the stomach. </li></ul><ul><li>Composed of a thick muscular layer, approx. 250mm long and 20mm diameter. </li></ul><ul><li>Epithelial cell function is mainly protective: </li></ul><ul><ul><li>simple mucus glands secret mucus into the narrow lumen to lubricate food and protect the lower part of the oesophagus from gastric acid. </li></ul></ul><ul><li>The pH of the oesophageal lumen is usually between 5 and 6. </li></ul><ul><li>The oesophageal transit of dosage form is approx. 10-14 seconds </li></ul>
  24. 25. Physiology of the GIT: The Stomach <ul><li>Most dilated part of the gastrointestinal tract. </li></ul><ul><li>Situated between the lower end of the oesophagus and the small intestine. </li></ul><ul><li>Opening to the duodenum is controlled by the pyloric sphincter. </li></ul><ul><li>Capacity of approx. 1.5L </li></ul><ul><li>Very little drug absorption occurs in the stomach due to relatively small surface area (compared to small intestines). </li></ul>
  25. 26. Physiology of the GIT: The Stomach (cont’d) <ul><li>Gastric secretions: </li></ul><ul><ul><li>Acid secreted by parietal cells - maintains the pH of the stomach between 1 and 3.5 in fasted state. </li></ul></ul><ul><ul><li>Hormone gastrin - potent stimulator of gastric acid production. </li></ul></ul><ul><ul><li>Pepsin - secreted by peptic cells in the form of its precursor, pepsinogen; peptidase which break down proteins to peptides at low pH; above pH 5 pepsin is denatured. </li></ul></ul><ul><ul><li>Mucus - secreted by the surface mucosal cells and lines the gastric mucosa; protects gastric mucosa from auto digestion by the pepsin-acid combination . </li></ul></ul>
  26. 27. Physiology of the GIT: The Small Intestine <ul><li>Longest (4-5m) and most convoluted part of the GIT, extending from the pyloric sphincter (of stomach) to the ileo-caecal junction where it joins the large intestines. </li></ul><ul><li>Main functions: </li></ul><ul><li>Digestion : </li></ul><ul><li>Process of enzymic degradation; begins in the stomach </li></ul><ul><li>and completed in the small intestine. </li></ul><ul><li>Absorption : </li></ul><ul><ul><li>Small intestine is the region where most nutrients and other materials are absorbed. </li></ul></ul><ul><li>Divided into the duodenum (200-300mm long), the jejunum (≈2m long) and the ileum (≈3m in length). </li></ul>
  27. 28. Physiology of the GIT: The Small Intestine (cont’d) <ul><li>The luminal pH of the small intestine increases to 6 -7.5 due to : </li></ul><ul><li>Brunner’s glands : </li></ul><ul><ul><li>Located in the duodenum </li></ul></ul><ul><ul><li>responsible for the secretion of bicarbonate which neutralizes the acid emptied from the stomach. </li></ul></ul><ul><li>Intestinal cells : </li></ul><ul><ul><li>present throughout the small intestine </li></ul></ul><ul><ul><li>secrete mucus and enzymes, such as hydrolases and proteases </li></ul></ul>
  28. 29. Physiology of the GIT: The Small Intestine (cont’d) <ul><li>The following structures are responsible for the very large surface area of the small intestine. </li></ul><ul><li>Folds of Kerckring: </li></ul><ul><ul><li>Submucosal folds extending circularly most of the way around the intestine; well developed in the duodenum and jejunum </li></ul></ul><ul><li>Villi: </li></ul><ul><ul><li>described as finger–like projections into the lumen </li></ul></ul><ul><ul><li>(approx. 0.5 - 1.5mm in length and 0.1mm in diameter). </li></ul></ul><ul><ul><li>Well perfused </li></ul></ul><ul><li>Microvilli: </li></ul><ul><ul><li>approximately 600-1000 brush-like structures (1  m in length and 0.1  m in width) cover each villus, </li></ul></ul><ul><ul><li>provides the largest increase in the surface area. </li></ul></ul>
  29. 30. Increase in Surface Surface Area Structure (relative to cylinder) sq cm simple cylinder 1 3,300 Folds of Kerckring 3 10,000 Villi 30 100,000 Microvilli 600 2,000,000
  30. 31. Physiology of the GIT: The Colon <ul><li>Terminal portion of GIT. </li></ul><ul><li>Unlike the small intestine, has no specialized villi. </li></ul><ul><li>However, the surface area is increased by the following </li></ul><ul><ul><li>microvilli of the absorptive epithelial cells </li></ul></ul><ul><ul><li>presence of crypts </li></ul></ul><ul><ul><li>irregular folded mucosae serve to increase the surface area of the colon by 10-15 times. </li></ul></ul><ul><li>Main functions are : </li></ul><ul><li>The absorption of sodium and chloride ions and water from the lumen in exchange for bicarbonate and potassium ions. </li></ul><ul><li>Significant homeostatic role in the body. </li></ul><ul><li>Storage and compaction of faeces. </li></ul>
  31. 32. Physiology of the GIT: The Colon (cont’d) <ul><li>Colonized by a large number and variety of bacteria (about 10 12 per gram of contents). </li></ul><ul><li>Bacterial mass is capable of several metabolic reaction, including hydrolysis of fatty acids, reduction of inactive conjugated drugs to their active form. </li></ul><ul><li>They degrade polysaccharide to produce short- chain fatty acids (acetic, proprionic butyric acids); generation of gases hydrogen, carbon dioxide and methane (lowers luminal pH to 6 - 6.5) </li></ul><ul><li>This increases to around 7-7.5. toward the distal parts of the colon. </li></ul>